<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-85364</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The aqueous formulation of amiodarone i.v. is safer than the formulation available in Spain</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Montero-Pérez, Francisco Javier</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Med. clín (Ed. impr.);136(1): 40-40, ene. 2011.</dc:source>
<dc:identifier>ibc-85364</dc:identifier>
<dc:title xml:lang="es">La formulación acuosa de amiodarona intravenosa es más segura que la formulación disponible en España</dc:title>
<dc:subject>^d51668</dc:subject>
<dc:subject>^d4401</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d19210</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d651^s22000</dc:subject>
<dc:subject>^d651^s29165</dc:subject>
<dc:type>article</dc:type>
<dc:date>201101</dc:date>
</metadata>
</record>
</ibecs-document>
